Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alí Duarte‐García"'
Autor:
Maria Margarida Cunha, Gabriela Schmajuk, Rebecca Hasseli, Namrata Singh, Tiffany Y.T. Hsu, Milena A. Gianfrancesco, Anja Strangfeld, Ranjeny Thomas, Naomi J Patel, Thierry Thomas, Philippe Dieudé, Kimme L. Hyrich, Emily Sirotich, Laura Trupin, Liselotte Tidblad, Jinoos Yazdany, René Marc Flipo, Licia Maria Henrique da Mota, Andrea M Seet, Samar Al Emadi, Carolina A. Isnardi, Saskia Lawson-Tovey, Alí Duarte-García, Hendrik Schulze-Koops, Manuel F. Ugarte-Gil, Vanessa L. Kronzer, Philip Robinson, Lindsay Jacobsohn, Elsa F Mateus, Pedro Machado, Ana Paula Monteiro Gomides, Jean W. Liew, Guillermo A. Berbotto, Miguel Bernardes, Patricia P. Katz, Martin Schäfer, Guillermo J. Pons-Estel, Ulf Müller-Ladner, Jeffrey A. Sparks, Elena Nikiphorou, Christof Specker, Paul Sufka, Zara Izadi, Loreto Carmona, Stephanie Rush, Sandra Lúcia Euzébio Ribeiro, Maria O Valenzuela-Almada, Kristin M. D’Silva, Emily L Gilbert, Raphaèle Seror, Laure Gossec, Beth I Wallace, Viviane Angelina de Souza, Akpabio Akpabio, Jérôme Avouac, Leanna Wise, Wendy Costello, Zachary S. Wallace, Suleman Bhana, Jonathan S. Hausmann, Lianne Kearsley-Fleet, Bernd Raffeiner, Carlo Alberto Scirè, Rebecca Grainger
Publikováno v:
Annals of the Rheumatic Diseases
Sparks, J A, Wallace, Z S, Seet, A M, Gianfrancesco, M A, Izadi, Z, Hyrich, K L, Strangfeld, A, Gossec, L, Carmona, L, Mateus, E F, Lawson-Tovey, S, Trupin, L, Rush, S, Katz, P, Schmajuk, G, Jacobsohn, L, Wise, L, Gilbert, E L, Duarte-García, A, Valenzuela-Almada, M O, Pons-Estel, G J, Isnardi, C A, Berbotto, G A, Hsu, T Y T, D'Silva, K M, Patel, N J, Kearsley-Fleet, L, Schäfer, M, Ribeiro, S L E, Al Emadi, S, Tidblad, L, Scirè, C A, Raffeiner, B, Thomas, T, Flipo, R M, Avouac, J, Seror, R, Bernardes, M, Cunha, M M, Hasseli, R, Schulze-Koops, H, Müller-Ladner, U, Specker, C, De Souza, V A, Da Mota, L M H, Gomides, A P M, Dieudé, P, Nikiphorou, E, Kronzer, V L, Singh, N, Ugarte-Gil, M F, Wallace, B, Akpabio, A, Thomas, R, Bhana, S, Costello, W, Grainger, R, Hausmann, J S, Liew, J W, Sirotich, E, Sufka, P, Robinson, P C, Machado, P M & Yazdany, J 2021, ' Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis : Results from the COVID-19 Global Rheumatology Alliance physician registry ', Annals of the rheumatic diseases, vol. 80, no. 9, pp. 1137-1146 . https://doi.org/10.1136/annrheumdis-2021-220418
Sparks, J A, Wallace, Z S, Seet, A M, Gianfrancesco, M A, Izadi, Z, Hyrich, K L, Strangfeld, A, Gossec, L, Carmona, L, Mateus, E F, Lawson-Tovey, S, Trupin, L, Rush, S, Katz, P, Schmajuk, G, Jacobsohn, L, Wise, L, Gilbert, E L, Duarte-García, A, Valenzuela-Almada, M O, Pons-Estel, G J, Isnardi, C A, Berbotto, G A, Hsu, T Y T, D'Silva, K M, Patel, N J, Kearsley-Fleet, L, Schäfer, M, Ribeiro, S L E, Al Emadi, S, Tidblad, L, Scirè, C A, Raffeiner, B, Thomas, T, Flipo, R M, Avouac, J, Seror, R, Bernardes, M, Cunha, M M, Hasseli, R, Schulze-Koops, H, Müller-Ladner, U, Specker, C, De Souza, V A, Da Mota, L M H, Gomides, A P M, Dieudé, P, Nikiphorou, E, Kronzer, V L, Singh, N, Ugarte-Gil, M F, Wallace, B, Akpabio, A, Thomas, R, Bhana, S, Costello, W, Grainger, R, Hausmann, J S, Liew, J W, Sirotich, E, Sufka, P, Robinson, P C, Machado, P M & Yazdany, J 2021, ' Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis : Results from the COVID-19 Global Rheumatology Alliance physician registry ', Annals of the rheumatic diseases, vol. 80, no. 9, pp. 1137-1146 . https://doi.org/10.1136/annrheumdis-2021-220418
ObjectiveTo investigate baseline use of biologic or targeted synthetic (b/ts) disease-modifying antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA).MethodsWe analysed the COVID-19 Global Rheumatology Alliance physician reg
Autor:
Jean W. Liew, Jeffrey A. Sparks, Alí Duarte-García, Michael S. Putman, Rebecca Grainger, Sebastian E. Sattui
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
We thank Tang et al. for their interest in our study and correspondence on an important clinical question. In May of 2020 when our literature search was last updated, we did not identify any case series, cohort studies, or randomized controlled trial
Autor:
Ariella Coler-Reilly, Peter Korsten, Alí Duarte-García, Emily Sirotich, Sebastian E. Sattui, Francis Berenbaum, Carly Harrison, Jeffrey A. Sparks, Manuel F. Ugarte-Gil, Maximilian F. Konig, Michael S. Putman, Jean W. Liew, Kate Webb, Kristen J. Young, Alfred H.J. Kim, Elizabeth R. Graef, Philip Robinson
Publikováno v:
Expert Review of Clinical Immunology
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Introduction Several months into the COVID-19 pandemic, safe and effective treatments against this global health disaster have yet to be identified. Clinical research trials around the world are underway testing a wide array of possible medications.
Autor:
Jean W. Liew, Maximilian F. Konig, Jeffrey A. Sparks, Elizabeth R. Graef, Alí Duarte-García, Alfred H.J. Kim
Publikováno v:
Annals of the Rheumatic Diseases
We appreciate the interest of Lo et al in our opinion piece and thank them for the data presented in their letter.1 2 Several reports of QT prolongation and torsades de pointes in patients with COVID-19 receiving antimalarials have been published.3
Autor:
Alfred H J, Kim, Jeffrey A, Sparks, Jean W, Liew, Michael S, Putman, Francis, Berenbaum, Alí, Duarte-García, Elizabeth R, Graef, Peter, Korsten, Sebastian E, Sattui, Emily, Sirotich, Manuel F, Ugarte-Gil, Kate, Webb, Rebecca, Grainger, Marc, Nolan
Publikováno v:
Annals of Internal Medicine
Annals of Internal Medicine, 2020, ⟨10.7326/M20-1223⟩
Annals of Internal Medicine, American College of Physicians, 2020, ⟨10.7326/M20-1223⟩
Annals of Internal Medicine, 2020, ⟨10.7326/M20-1223⟩
Annals of Internal Medicine, American College of Physicians, 2020, ⟨10.7326/M20-1223⟩
Hydroxychloroquine, an essential treatment for many patients with rheumatologic conditions, has garnered widespread attention as a potential treatment for COVID-19 infection. The authors appraise t...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3db700f35b57719826799ff32b6c83cb
https://www.hal.inserm.fr/inserm-02552186
https://www.hal.inserm.fr/inserm-02552186
Autor:
Jinoos Yazdany, L. Mathias, A E Clarke, Kristin M. D’Silva, Zachary S. Wallace, S. Al Emadi, Graciela S. Alarcón, Elena Nikiphorou, Emily L Gilbert, P.P. Katz, Milena A. Gianfrancesco, Andrea M Seet, C. Reategui Sokolova, Philip Robinson, Leanna Wise, Sasha Bernatsky, Ranjeny Thomas, Beth I Wallace, Naomi Serling-Boyd, Guillermo J. Pons-Estel, Manuel F. Ugarte-Gil, Vanessa L. Kronzer, Tiffany Hsu, Wendy Costello, Jonathan S. Hausmann, P. Dieudé, Rebecca Grainger, Elsa F Mateus, Pedro Machado, Suleman Bhana, Stephanie Rush, Gabriela Schmajuk, KL Hyrich, Laura Trupin, Jean W. Liew, Paul Sufka, N. Lim, Lindsay Jacobsohn, Akpabio Akanimo Akpabio, Laure Gossec, Maria José Santos, Maria O Valenzuela-Almada, Zara Izadi, Namrata Singh, L. Carmona, Saskia Lawson-Tovey, Jeffrey A. Sparks, Alí Duarte-García, Emily Sirotich, Anja Strangfeld
Publikováno v:
Annals of the Rheumatic Diseases. 80:173.2-175
Background:An increased risk of severe COVID-19 outcomes may be seen in patients with autoimmune diseases on moderate to high daily doses of glucocorticoids, as well as in those with comorbidities. However, specific information about COVID-19 outcome
Autor:
Pedro Machado, Naomi Serling-Boyd, Alí Duarte-García, Suleman Bhana, Jean W. Liew, Paul Sufka, Lindsay Jacobsohn, Anja Strangfeld, Emily Sirotich, L. Carmona, Rebecca Grainger, Saskia Lawson-Tovey, Laura Trupin, Wendy Costello, S. Al Emadi, Jeffrey A. Sparks, Kristin M. D’Silva, Jonathan S. Hausmann, KL Hyrich, P.P. Katz, Jinoos Yazdany, Tiffany Y.T. Hsu, Leanna Wise, Stephanie Rush, Gabriela Schmajuk, Zachary S. Wallace, Zara Izadi, Emily L Gilbert, Laure Gossec, Maria O Valenzuela-Almada, Milena A. Gianfrancesco, Philip Robinson, Elsa F Mateus
Publikováno v:
Annals of the Rheumatic Diseases. 80:175.2-176
Background:Acute Respiratory Distress Syndrome (ARDS) is a life-threatening complication of COVID-19 and has been reported in approximately one-third of hospitalized patients with COVID-191. Risk factors associated with the development of ARDS includ